Capri EGM, a Chicago-based investment company that focuses on net lease, sale-leaseback and build-to-suit transactions, has agreed to sell a life science distribution facility leased to Sanofi Genzyme for $33 million.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties